Goyal MK, Hatwal J, Desai R, Sehgal T, Batta A. Do biomarkers matter? Cardiovascular risk stratification in Asian patients with metabolic dysfunction-associated steatotic liver disease in the era of fibrosis-centric assessment. World J Gastroenterol 2026; 32(28): 117181 [DOI: 10.3748/wjg.117181]
Mohamed Yousef Abdallah Y. Omar, Amany Mansour E. El-mallah, Mohamed Gamal M.A. Bakr, Mohamed Mahmoud E. Ragab. Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation. American Heart Journal Plus: Cardiology Research and Practice 2026; 70doi: 10.1016/j.ahjo.2026.100865